{"title": "Global Health Drug Discovery Institute on LinkedIn: Tuberculosis vaccine passes safety test", "author": "5", "url": "https://www.linkedin.com/posts/ghddi_tuberculosis-vaccine-passes-safety-test-activity-6976329196600012801-hOKm", "hostname": "linkedin.com", "description": "A clinical trial in South Africa has reportedly shown that a new vaccine candidate for protection against tuberculosis (TB) is safe for newborns with and...", "sitename": "Linkedin", "date": "2022-09-16", "cleaned_text": "clinical trial in South Africa has reportedly shown that a new vaccine candidate for protection against tuberculosis (TB) is safe for newborns with and without HIV exposure and has fewer side effects than Bacillus Calmette Gu\u00e9rin (BCG) - the only TB vaccine that has been administered for a century. The VPM1002 vaccine, developed by Max Planck researchers, is also being evaluated in adults in two other phase III clinical trials in India. TB is the second leading infectious killer after COVID-19 in the world but a neglected disease at the same time. As one of the main drug research focuses of [Global Health Drug Discovery Institute](https://cn.linkedin.com/company/ghddi?trk=public_post-text), we are glad to hear of this encouraging progress in developing a new TB vaccine that may protect more people against the illness. Learn more about "}